GlassScriptPhysician profile
Traci E Ridgway
NPI 1972265643
$1,378.87
in general payments reported to CMS, 2019-2025
20 companies · $267 in 2025
The $267 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $315 · 2023: $398 · 2024: $400 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,064.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,064.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $655.76 | 2022-2024 | Trodelvy |
| Novartis Pharmaceuticals Corporation | $165.23 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $108.27 | 2022-2025 | Keytruda, Keytruda Qlex |
| Pfizer INC. | $80.10 | 2023-2025 | |
| Janssen Biotech, INC. | $57.52 | 2024 | Darzalex, Tecvayli, Talvey |
| E.R. Squibb & Sons, L.L.C. | $48.43 | 2022-2025 | Opdivo |
| Stemline Therapeutics INC. | $33.20 | 2023-2025 | Orserdu |
| Exelixis INC. | $30.44 | 2025 | Cabometyx |
| Tempus Ai, INC | $24.50 | 2025 | Xt Cdx |
| Smith+Nephew, INC. | $20.53 | 2025 | Stravix Pl, Oasis, Grafix Pl |
| Foundation Medicine, INC. | $20.26 | 2023 | |
| Abbvie INC. | $19.15 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.49 | 2022 | |
| Aveo Pharmaceuticals, INC. | $16.88 | 2022 | |
| Seagen INC. | $14.84 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $14.42 | 2023 | Xtandi |
| Puma Biotechnology, INC. | $13.56 | 2022 | |
| Cti Biopharma Corp. | $13.28 | 2022 | |
| Janssen Pharmaceuticals, INC | $12.32 | 2022 | |
| Lilly USA, LLC | $11.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Traci Ridgway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.